Skip to main content
Top
Published in: Diabetologia 6/2011

01-06-2011 | Article

Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice

Authors: C. Alam, E. Bittoun, D. Bhagwat, S. Valkonen, A. Saari, U. Jaakkola, E. Eerola, P. Huovinen, A. Hänninen

Published in: Diabetologia | Issue 6/2011

Login to get access

Abstract

Aims/hypothesis

Microbial factors influence the development of diabetes in NOD mice. Studies in germ-free animals have revealed important roles of microbiota in the regulation of Th17 and forkhead box P3 (FOXP3)+ T regulatory (Treg) activation in the intestine. However, the effects of intestinal microbiota in immune regulation and diabetes development in NOD mice are still poorly understood.

Methods

A colony of germ-free NOD mice was established to evaluate the effects of intestinal microbiota on regulatory immunity in the gut, and on the development of insulitis and diabetes in NOD mice.

Results

Diabetes developed in roughly equal numbers in germ-free and specific pathogen-free NOD mice. Insulitis was accentuated in germ-free NOD mice; yet insulin preservation was unaltered. Germ-free NOD mice showed increased levels of Il17 (also known as Il17a) mRNA in the colon, and of Th17 and Th1 cells in the mesenteric and pancreatic lymph nodes, while Foxp3 mRNA and FOXP3+ Tregs were reduced. In the islet infiltrates, FOXP3+CD4+ T cells were slightly increased in germ-free mice. B cells appeared less activated in the peritoneum and were less abundant in islet infiltrates.

Conclusions/interpretation

These results indicate that lack of intestinal microbiota promotes an imbalance between Th1, Th17 and Treg differentiation in the intestine. This imbalance is associated with accelerated insulitis, but intact recruitment of FOXP3+ Tregs into islets, suggesting: (1) a microbial dependence of local induction of Treg in the gut and draining lymph nodes; but (2) a potentially compensatory function of naturally occurring Tregs in the islets, which may help control diabetogenic T cells.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP (2010) Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53:741–748PubMedCrossRef Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP (2010) Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53:741–748PubMedCrossRef
3.
go back to reference Vaarala O, Atkinson MA, Neu J (2008) The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555–2562PubMedCrossRef Vaarala O, Atkinson MA, Neu J (2008) The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555–2562PubMedCrossRef
4.
go back to reference Wen L, Ley RE, Volchkov PY et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109–1113PubMedCrossRef Wen L, Ley RE, Volchkov PY et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109–1113PubMedCrossRef
5.
go back to reference Suzuki T, Yamado T, Takao T, Fujimura T, Kawamura E, Shimizu M, Yamashita R, Nomoto K (1987) Diabetogenic effects of lymphocyte transfusion on the NOD or NOD nude mouse. Karger, Basel Suzuki T, Yamado T, Takao T, Fujimura T, Kawamura E, Shimizu M, Yamashita R, Nomoto K (1987) Diabetogenic effects of lymphocyte transfusion on the NOD or NOD nude mouse. Karger, Basel
6.
go back to reference Taniguchi H, Makino S, Ikegami H (2007) The NOD mouse and its related strains. CRC, Boca Raton Taniguchi H, Makino S, Ikegami H (2007) The NOD mouse and its related strains. CRC, Boca Raton
7.
go back to reference Nieuwenhuis EE, Matsumoto T, Lindenbergh D et al (2009) Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 119:1241–1250PubMedCrossRef Nieuwenhuis EE, Matsumoto T, Lindenbergh D et al (2009) Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 119:1241–1250PubMedCrossRef
8.
go back to reference Petnicki-Ocwieja T, Hrncir T, Liu YJ et al (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106:15813–15818PubMedCrossRef Petnicki-Ocwieja T, Hrncir T, Liu YJ et al (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106:15813–15818PubMedCrossRef
9.
go back to reference Ishikawa H, Tanaka K, Maeda Y et al (2008) Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells. Clin Exp Immunol 153:127–135PubMedCrossRef Ishikawa H, Tanaka K, Maeda Y et al (2008) Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells. Clin Exp Immunol 153:127–135PubMedCrossRef
10.
go back to reference Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36:2336–2346PubMedCrossRef Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36:2336–2346PubMedCrossRef
11.
go back to reference Min B, Thornton A, Caucheteux SM et al (2007) Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol 37:1916–1923PubMedCrossRef Min B, Thornton A, Caucheteux SM et al (2007) Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol 37:1916–1923PubMedCrossRef
12.
go back to reference Atarashi K, Nishimura J, Shima T et al (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808–812PubMedCrossRef Atarashi K, Nishimura J, Shima T et al (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808–812PubMedCrossRef
13.
go back to reference Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498PubMedCrossRef Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498PubMedCrossRef
14.
go back to reference Schenk U, Westendorf AM, Radaelli E et al (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1:ra6PubMedCrossRef Schenk U, Westendorf AM, Radaelli E et al (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1:ra6PubMedCrossRef
15.
go back to reference Zaph C, Du Y, Saenz SA et al (2008) Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205:2191–2198PubMedCrossRef Zaph C, Du Y, Saenz SA et al (2008) Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205:2191–2198PubMedCrossRef
16.
go back to reference Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A (2010) Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 59:2237–2246PubMedCrossRef Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A (2010) Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 59:2237–2246PubMedCrossRef
17.
go back to reference Kendall PL, Woodward EJ, Hulbert C, Thomas JW (2004) Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol 34:2387–2395PubMedCrossRef Kendall PL, Woodward EJ, Hulbert C, Thomas JW (2004) Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol 34:2387–2395PubMedCrossRef
18.
go back to reference Alam C, Valkonen S, Ohls S, Tornqvist K, Hanninen A (2010) Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia 53:346–355PubMedCrossRef Alam C, Valkonen S, Ohls S, Tornqvist K, Hanninen A (2010) Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia 53:346–355PubMedCrossRef
19.
go back to reference Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S (2005) Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 166:793–800PubMedCrossRef Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S (2005) Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 166:793–800PubMedCrossRef
20.
go back to reference Pesti L (1979) Intestinal microflora: elimination of germfree characteristics by components of the normal microbial flora. Comp Immunol Microbiol Infect Dis 1:141–152PubMedCrossRef Pesti L (1979) Intestinal microflora: elimination of germfree characteristics by components of the normal microbial flora. Comp Immunol Microbiol Infect Dis 1:141–152PubMedCrossRef
21.
go back to reference Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H (2008) Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol 9:65PubMedCrossRef Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H (2008) Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol 9:65PubMedCrossRef
22.
go back to reference Maksimow M, Alam C, Hanninen A (2008) Incomplete killing and enhanced activation of islet-reactive CD8+ T cells by FasL-expressing dendritic cells limits protection from diabetes. Rev Diabet Stud 5:144–153PubMedCrossRef Maksimow M, Alam C, Hanninen A (2008) Incomplete killing and enhanced activation of islet-reactive CD8+ T cells by FasL-expressing dendritic cells limits protection from diabetes. Rev Diabet Stud 5:144–153PubMedCrossRef
23.
go back to reference Chen Z, Herman AE, Matos M, Mathis D, Benoist C (2005) Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387–1397PubMedCrossRef Chen Z, Herman AE, Matos M, Mathis D, Benoist C (2005) Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387–1397PubMedCrossRef
24.
go back to reference Ryan GA, Wang CJ, Chamberlain JL et al (2010) B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 185:2800–2807PubMedCrossRef Ryan GA, Wang CJ, Chamberlain JL et al (2010) B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 185:2800–2807PubMedCrossRef
25.
go back to reference Fiorina P, Vergani A, Dada S et al (2008) Targeting CD22 reprograms B cells and reverses autoimmune diabetes. Diabetes 57:3013–3024PubMedCrossRef Fiorina P, Vergani A, Dada S et al (2008) Targeting CD22 reprograms B cells and reverses autoimmune diabetes. Diabetes 57:3013–3024PubMedCrossRef
26.
go back to reference Hu CY, Rodriguez-Pinto D, Du W et al (2007) Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117:3857–3867PubMedCrossRef Hu CY, Rodriguez-Pinto D, Du W et al (2007) Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117:3857–3867PubMedCrossRef
27.
go back to reference Ha SA, Tsuji M, Suzuki K et al (2006) Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 203:2541–2550PubMedCrossRef Ha SA, Tsuji M, Suzuki K et al (2006) Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 203:2541–2550PubMedCrossRef
28.
go back to reference Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495–549PubMedCrossRef Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495–549PubMedCrossRef
Metadata
Title
Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice
Authors
C. Alam
E. Bittoun
D. Bhagwat
S. Valkonen
A. Saari
U. Jaakkola
E. Eerola
P. Huovinen
A. Hänninen
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2097-5

Other articles of this Issue 6/2011

Diabetologia 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.